Pharmacotherapies for problematic psychostimulant use: a review of current research

Drug and Alcohol Review
James Shearer, Linda R Gowing

Abstract

This review summarizes the current status of clinical research on pharmacotherapies for problematic psychostimulant use. The use of psychostimulants, including amphetamine, cocaine and ecstasy, is increasingly a feature of Australian life as is the presentation of patients with psychostimulant disorders. A lack of experience, resources and treatment options have constrained the response of treatment services to such problems. Despite extensive research, particularly in the area of cocaine, no pharmacotherapy has been proven effective in the management of psychostimulant disorders. The harms associated with problematic psychostimulant use warrant further controlled research in innovative approaches integrated with psychosocial interventions.

References

Aug 1, 1976·Archives of General Psychiatry·M W FischmanD X Freedman
Jan 1, 1991·Journal of Substance Abuse Treatment·W S CondelliJ V Rachal
Sep 3, 1990·The Medical Journal of Australia·J P Sherman
Aug 1, 1985·The International Journal of the Addictions·D L StrugB Spunt
May 6, 1972·British Medical Journal·R Gardner, P H Connell
Jun 21, 1969·British Medical Journal·D HawksG Edwards
Aug 1, 1995·The American Journal of Drug and Alcohol Abuse·L CoviC A Haertzen
Feb 1, 1995·Journal of Clinical Psychopharmacology·N W WithersJ C Gillin
Jun 1, 1994·Journal of the Royal Society of Health·P M Fleming, D Roberts
Apr 1, 1993·The American Journal of Psychiatry·J GrabowskiD Creson
Jan 1, 1993·Journal of Addictive Diseases·C S Tutton, J W Crayton
Oct 1, 1995·Drug and Alcohol Dependence·E V NunesD F Klein
May 16, 1996·The New England Journal of Medicine·F H GawinP Jatlow
Apr 1, 1996·Clinical Pharmacology and Therapeutics·R D CrosbyN L Graves
Nov 1, 1995·Journal of Substance Abuse Treatment·A OlivetoD Ziedonis
Jun 1, 1996·Drug and Alcohol Dependence·S L BatkiR T Jones
Nov 1, 1996·Journal of Substance Abuse Treatment·G P GallowayD Smith
Dec 31, 1997·Journal of Clinical Psychopharmacology·J GrabowskiA Korszun
Jul 3, 1998·Drug and Alcohol Dependence·I PetrakisB Rounsaville
Aug 26, 1998·Drug and Alcohol Dependence·F J White, P W Kalivas
Oct 27, 1998·Drug and Alcohol Dependence·E F McCance-KatzP Jatlow
May 18, 1999·Science·G J Nossal
Jun 1, 2000·Journal of Clinical Psychopharmacology·J GrabowskiR Bailey
Jul 27, 2000·Annals of the New York Academy of Sciences·K A SevarinoT R Kosten
Dec 1, 2000·The American Journal of Psychiatry·K M KampmanC P O'Brien
Apr 5, 2001·Journal of Addictive Diseases·R MalcolmK T Brady
Apr 24, 2001·Addictive Behaviors·J M SchmitzJ Grabowski
May 30, 2001·Drug and Alcohol Dependence·A OlivetoT R Kosten
Jun 22, 2001·Drug and Alcohol Dependence·J M SchmitzJ Grabowski
Oct 11, 2001·Journal of Clinical Psychopharmacology·J GrabowskiF G Moeller
Jan 23, 2002·Vaccine·Thomas R KostenBarbara Fox
May 1, 2002·Behavioural Pharmacology·C R RushA F Wooten

❮ Previous
Next ❯

Citations

Oct 1, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Mark K GreenwaldCaren L Steinmiller
Apr 20, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David VlahovSteffanie A Strathdee
May 19, 2007·Addiction Biology·Antonio Preti
Dec 19, 2006·Journal of Substance Abuse Treatment·James Shearer
Nov 11, 2008·Annals of the New York Academy of Sciences·Richard B RothmanMichael H Baumann
Nov 16, 2006·Annals of the New York Academy of Sciences·Richard B Rothman, Michael H Baumann
Mar 6, 2010·Annals of the New York Academy of Sciences·David V HerinJohn Grabowski
Jun 23, 2010·Drug and Alcohol Review·James ShearerRichard P Mattick
Sep 4, 2004·Addictive Behaviors·John GrabowskiS Stevens Negus
Apr 25, 2016·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Yan ZhaoMin Zhao
Mar 12, 2005·The Journal of Pharmacology and Experimental Therapeutics·Richard B RothmanMichael H Baumann
Apr 25, 2007·Drug and Alcohol Review·Alison Ritter
Mar 28, 2008·Drug and Alcohol Review·James Shearer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
Charles A DackisCharles P O'Brien
Journal of Substance Abuse Treatment
Margaret CretzmeyerJames A Hall
© 2021 Meta ULC. All rights reserved